Indian Liver Disease Drugs Market Analysis


  • Type: Therapeutics Area
  • Published : April 2021
  • Region: Asia
  • Country: India
  • Report ID : 1210

  • Format: PPT, PDF

Indian Liver Disease Drugs Market Segmented by treatment (Vaccines, Antiviral, Corticosteroids, Anabolic Steroids, Antimetabolites, Anti-Rejection Drugs, Immunosuppressive Agents, Immune Globulins, and Chemotherapy) by Drug type (Vaccines, Chemotherapy, Antiviral, Corticosteroids, Anabolic Steroids, Antimetabolites, Anti-Rejection Drugs, Immunosuppressive Agents, Immune Globulins) by End- User (Hospitals, Adult Liver Disease Treatment Centre, Ambulatory Surgical Centre) Forecast 2019-2028.

SKU: 1210 Categories: ,

Report Overview

Indian Liver Disease Drugs Market size stood at USD XX billion in 2019 and is projected to reach USD XX billion by 2028, exhibiting a CAGR of XX% during the forecast period (2019-2028).

India has been witnessing a rise in liver disease cases. Sedentary lifestyle, increase in non-communicable disorders like hypertension, obesity, and diabetes, etc have led liver disease to become the 10th most common cause of death. Around 10 lakh patients of liver cirrhosis are newly diagnosed every year in India, Liver disease affects every one in 5 Indians. In north India, 97 per cent of liver transplants are Living Donor Liver transplants, whereas only 3 per cent are cadaver (after brain death) transplants. Increasing prevalence of diseases such as hepatitis and liver cancer is expected to support growth of the market over the forecast period. The increasing rates of geriatric population have resulted in rise of the incidences of liver diseases, which further escalating the demand of liver disease treatment market.

Market Drivers

Liver diseases therapeutic market is growing due to factors like in geriatric population, increasing prevalence of liver disease, government initiative of providing vaccines and growing awareness, change in lifestyle related diseases, increase in consumption of alcohol and improper diet and increase in research and development activities by companies. Growing habit of alcohol consumption, unhealthy diets increased the reasons for liver damage. This has accelerated the growth of Liver Disease Market Industry. Non-alcohol fatty liver disease is expected to increase on high rate during the forecast period and this will expand the market size of liver disease treatment industry. Rising prevalence of acute and chronic liver diseases is one of the major factors expected to drive the market for liver disease diagnostics. The favorable reimbursement policies by various health insurance programs is accelerating the market for liver disease diagnostics in India.

1. Indian Liver Disease Treatment Market Overview………………………………..
A. Market Size
2. Market Growth Drivers………………………………………………………………….
A. Rise in Global Prevalence of Liver Disease
B. Growing R&D Investments and Reimbursement Policies
3. Type of Liver Diseases……………………………………………………………………………….
A. Hepatitis A
B. Hepatitis B
C. Hepatitis C
D. Wilson Disease
4. Liver Disease Market Segmentation………………………………………………
A. Treatment
I. Vaccines
II. Antiviral
III. Corticosteroids
IV. Anabolic Steroids
V. Antimetabolites
VI. Anti-Rejection Drugs
VII. Immunosuppressive Agents
VIII. Immune Globulins
IX. Chemotherapy
B. Drug Type
I. Vaccines
II. Chemotherapy
III. Antiviral
IV. Corticosteroids
V. Anabolic Steroids
VI. Antimetabolites
VII. Anti-Rejection Drugs
VIII. Immunosuppressive Agents
IX. Immune Globulins
C. End- User
I. Hospitals
II. Adult Liver Disease Treatment Centre
III. Ambulatory Surgical Centre
5. Liver Disease Major Drugs Market Share……………………………………..
A. Market Analysis, Insights and Forecast – By Revenue
6. Competitive Landscape…………………………………………………………………
A. Major Players
B. Products in Pipeline
7. Key Company Profiles…………………………………………………………………..
A. Abbott Laboratories Company overview, Product & Services, Strategies & Financials
B. Glaxosmithkline Plc. Company overview, Product & Services, Strategies & Financials
C. Zydus Pharmaceuticals Company, Product & Services, Strategies & Financials
8. Healthcare Policies and Regulatory Landscape…………………………………
A. Policy changes and Reimbursement scenario
9. Factors Driving Future Growth……………………………………………………
A. New Trends and Development of Liver Disease Drugs market
B. Future Opportunities
10. Conclusion

Market Segmentation

By treatment:

Liver diseases therapeutic market in India is segmented on the basis of type of treatment as antiviral drugs, vaccines, chemotherapy, targeted therapy, immunosuppressant, immunoglobulins, corticosteroids. The chemotherapy is mostly commonly used treatment type.

By Drug Type:

Liver disease therapeutic market in India is further segmented on the basis of drug type as Vaccines, Antiviral, Corticosteroids, Anabolic Steroids, Antimetabolites, Anti-Rejection Drugs, Immunosuppressive Agents, Immune Globulins and Chemotherapy.

By End- User:

On the basis of end- user the market is segmented into hospitals, adult liver disease treatment centre and ambulatory surgical centre. Hospitals provide optimal care to patients and enable early detection & diagnosis, thus boosting the growth of the market for liver disease diagnostics.

Major Players

Liver diseases are commonly caused by Hepatitis B and C, the other common causes of liver disease can now be called alcohol and other obesity related disorders. There has been a paradigm shift in the dynamics of liver cirrhosis and about 10 lakh new patients are diagnosed with it every year in India .Abbott Laboratories , Bayer Schering AG, Glaxosmithkline PlC, Merck & Co.,Takeda Pharmaceuticals, Zydus Pharmaceuticals Inc. are the major players of Liver disease treatment market in India. Zydus Pharmaceuticals is rapidly growing with XX% in Liver Drugs Market in India. Zydus Cadila announced that the Drug Controller General of India (DCGI) has approved its new drug application of Saroglitazar for the treatment of non-cirrhotic non-alcoholic steatohepatitis (NASH). Zydus achieved positive results in EVIDENCES II trial, a Phase 3 liver biopsy trial of Saroglitazar 4 mg versus Placebo in Indian patients with NASH.

Research Methodology

Insights10 will provide you reports within 10 key parameters which are:

  1. Market overview
  2. Market growth drivers & restraints
  3. Epidemiology or disease type
  4. Market segmentation
  5. Market share
  6. Competitive landscape
  7. Key company profiles
  8. Healthcare policies & regulatory framework
  9. Reimbursement scenario
  10. Factors driving future growth

Based on our many years of experience, we believe that these are the parameters that are critical to decision making for business stakeholders. Our focused approach to develop reports focused on 10 key parameters, enabled us to arrive at the name “Insights10”.

Our analysis methodology involves three critical stages:

Stage I: Market Data Collection

Primary Interviews: We have developed a network of experts, freelancers and researchers across countries through which we engage with local experts to gather key data points and assumptions around each market. We also engage regularly with some of the best market research agencies such as Atheneum, GuidePoint, GLG, etc. to conduct surveys and interviews, and build intelligence. We have language translators as a part of our team, who between them can cover 30+ languages allowing us to extract better local insights.

Secondary Data Collection: We have developed strong expertise and experience in secondary data collection methods for developing unique data sets and research material. We gather data from multiple reliable sources to maintain the high level of accuracy and consistency. The market data is analysed and forecasted using appropriate statistical and coherent models. The report offers an overall analysis of the market size, growth, market share as well as segment-level analysis of the specific market. Our report includes precise, to the point information related to the overall market, competition, growth drivers, challenges, regulatory updates, and competition.

Data Sources: We have access to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. The key sources of information include the following, but are not limited to:

  • Statistical Databases
  • Company Websites/Annual Reports
  • Trade Publications
  • Online Databases
  • Published Research Reports
  • Whitepapers
  • Press Releases of Key Market Players

Stage II: Market Data Analysis and Statistical Model

Market Trends: We generally look at macro parameter and micro indicators. The macro parameters includes changes in government policies, demand and supply of the market, government intervention programs and major market share. The micro indicators GDP growth, market size, market volume etc. We also understand nuances specific to each country like US, Canada, India, Germany, etc. and have worked across 60+ countries and hence no only understand global trends, but how these differ by country, how payment models, market structure, cultural parameters, etc. differ in each country.

Market Sizing and Analysis: Our expert data analytics team has created various market forecast models by employing the top-down approach i.e. start with large overall market and segment different areas and bottom-up approach i.e. start with population and epidemiology and roll up based on spend, etc., estimating the size of the market, and distributing among the geographic and/or product segments.

The top-down approach mainly used for new product forecasting and bottom-up approach is used for demand estimation of any product for different countries summed up to form total market. We are able to round off insights and build stronger forecasts because we always do both these methods and triangulate the final numbers.

The study on the market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific, and Africa for the period of 2020 to 2028. The qualitative analysis covers the industry landscape and trends, market opportunities, competitive landscape and policy and regulatory scenario and the quantitative analysis covers different market estimates and forecasts.

Data Triangulation & Validation:

Data triangulation of various sources and results of the research are carried out by benchmarking with reliable sources such as industry statistics, statistical databases and the company level averages etc.

We make sure to finalize the numbers in alignment to the market research. Firstly, our internal experts ensure thorough validation and checking to ensure the accurate and precise analysis and then validation is also done using multiple data analysis model.  Two level validation is done and entails finalization of report scope and to way of representation pattern.

Stage III: Interpretation and Presentation

Analysis & Interpretation: The information gathered is then analysed and synthesized. A second series of interviews are done if necessary to check and validate. The future opportunities are analysed by understanding product commercialization and many other factors. It also comprises the analysis of data discrepancies observed across various data sources. Information procured from secondary and primary results are then, interpreted by considering following parameters: (a partial list)

  • Establishing market drivers and trends
  • Analyzing regulatory landscape to understand future growth
  • Market Segment based analysis to obtain revenue / volume
  • Analyzing current needs and determining penetration to estimate market

Insights: Our reports deliver actionable insights backed with supporting facts and figures to assist you in achieving exemplary growth. Our in-depth analyses are interspersed with relevant insights and statistics to offer an executive-level view of a given market. The description helps in correlating many minor factors affecting the market and its impact to the different segments within the market.
Data curated from the analysis and interpretation are drawn to portray all in one consolidated report.

Presentation & Reporting: The market research report is presented in different forms such as charts by using a scientific approach for easy understanding. Historic, current and future analysis is provided for each market in terms of both value and volume. The size of the market is interpreted in the US Dollar value and the respective unit, based on the product, for volume consumptions.
The foreign exchange rates are calculated on the respective dates and for the respective regions covered in the study.

To request a free sample copy this report, please complete the form below.

    We value your inquiry and offer free customization with every report to fulfil your exact research needs.

    This website is secure and your personal details are safe.

    This report addresses

    • Market intelligence to enable effective decision making
    • Growth opportunities and trend analysis
    • Competitive benchmarking
    • Historical data & forecasts
    • Regional opportunities

    Need more?

    • Speak to our analyst to know how this research was put together
    • Add more countries or regions as part of customisation
    • Understand how this report can have direct impact on your revenue

    Get a custom report based on your requirements